The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Determination of Vitreous, Aqueous, and Plasma Concentration of OrallyAdministered Voriconazole in Humans
Abstract
OBJECTIVE: To investigate the penetration of voriconazole, a new-generation triazole antifungal agent, into the vitreous and aqueous humor after oral administration. METHODS: A prospective, nonrandomized clinical study included 14 patients scheduled for elective pars plana vitrectomy surgery between December 1, 2002, and February 28, 2003, at the Cullen Eye Institute, Houston, Tex. Aqueous, vitreous, and plasma samples were obtained and analyzed from 14 patients after oral administration of two 400-mg doses of voriconazole taken 12 hours apart before surgery. Assays were performed by means of high-performance liquid chromatography. RESULTS: Mean +/- SD voriconazole concentrations in plasma (n = 14), vitreous (n = 14), and aqueous (n = 11) were 2.13 +/- 0.93 microg/mL, 0.81 +/- 0.31 microg/mL, and 1.13 +/- 0.57 microg/mL, respectively. Mean +/- SD sampling times after oral administration of the second voriconazole dose for plasma, vitreous, and aqueous were 2.4 +/- 0.6 hours, 3.0 +/- 0.5 hours, and 2.9 +/- 0.5 hours, respectively. The percentages of plasma voriconazole concentration achieved in the vitreous and aqueous were 38.1% and 53.0%, respectively. Mean vitreous and aqueous minimum inhibitory concentrations for 90% of isolates (MIC(90)) were achieved against a wide spectrum of yeasts and molds, including Aspergillus species and Candida species, along with many other organisms. CONCLUSIONS: Orally administered voriconazole achieves therapeutic aqueous and vitreous levels in the noninflamed human eye, and the activity spectrum appears to appropriately encompass the most frequently encountered mycotic species involved in the various causes of fungal endophthalmitis. Because of its broad spectrum of coverage, low MIC(90) levels for the organisms of concern, good tolerability, and excellent bioavailability with oral administration, it may represent a major advance in the prophylaxis or management of exogenous or endogenous fungal endophthalmitis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Espinel-Ingroff, A., Boyle, K., & Sheehan, D. J. (2001) · Mycopathologia · doi:10.1023/a:1010954803886 · Cited by 251
Intraocular Candidiasis in Patients with Candidemia
Donahue, S. P., Greven, C. M., Zuravleff, J. J., Eller, A. W., Nguyen, M. H., Peacock, J. E., Wagener, M. M., & Yu, V. L. (1994) · Ophthalmology · doi:10.1016/s0161-6420(94)31175-4 · Cited by 239
Exogenous Fungal Endophthalmitis
Pflugfelder, S. C., Flynn, H. W., Zwickey, T. A., Forster, R. K., Tsiligianni, A., Culbertson, W. W., & Mandelbaum, S. (1988) · Ophthalmology · doi:10.1016/s0161-6420(88)33229-x · Cited by 216
Voriconazole: A New Triazole Antifungal
Sabo, J., & Abdel‐Rahman, S. M. (2000) · Annals of Pharmacotherapy · doi:10.1345/aph.19237 · Cited by 190
Fungal Endophthalmitis Following Intraocular Lens Implantation: A Surgical Epidemic
Pettit, T. H. (1980) · Archives of Ophthalmology · doi:10.1001/archopht.1980.01020031015002 · Cited by 187
Endogenous Endophthalmitis Among Patients with Candidemia
Parke, D. W., Jones, D. B., & Gentry, L. O. (1982) · Ophthalmology · doi:10.1016/s0161-6420(82)34722-3 · Cited by 166
Voriconazole -- better chances for patients with invasive mycoses.
Ghannoum, M. A., & Kuhn, D. M. (2002) · PubMed · Cited by 150
Ocular Penetration of Amphotericin B
GREEN, W. R. (1965) · Archives of Ophthalmology · doi:10.1001/archopht.1965.00970030771004 · Cited by 148
Sponsel, W. E., Graybill, J. R., Nevarez, H. L., & Dang, D. (2002) · British Journal of Ophthalmology · doi:10.1136/bjo.86.7.829-a · Cited by 123
Toxicity of Intravitreal Injection of Amphotericin B
Axelrod, A. J., Peyman, G. A., & Apple, D. J. (1973) · American Journal of Ophthalmology · doi:10.1016/0002-9394(73)90753-8 · Cited by 120
Cited by
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
Brüggemann, R. J. M., Alffenaar, J. C., Blijlevens, N. M. A., Billaud, E. M., Kosterink, J. G. W., Verweij, P. E., & Burger, D. M. (2009) · Clinical Infectious Diseases · doi:10.1086/598327 · Cited by 457
Tissue Penetration of Antifungal Agents
Felton, T., Troke, P. F., & Hope, W. W. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00046-13 · Cited by 426
Nett, J. E., & Andes, D. R. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2015.10.012 · Cited by 351
Metadata
- Authors
- Hariprasad, S. M.
- Venue
- Archives of Ophthalmology
- Publisher
- American Medical Association (AMA)
- Published
- 2004-01-01
- Volume
- 122
- Issue
- 1
- Pages
- 42
- ISSN
- 0003-9950 (ISSN-L)
- OpenAlex
- W2062329228
- Cited by
- 312
- References
- 20
- FWCI
- 18.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Determination of Vitreous, Aqueous, and Plasma Concentration of OrallyAdministered Voriconazole in Humans. https://app.cochat.ai/papers/10.1001/archopht.122.1.42
- The paper
- Hariprasad, S. M. (2004). Determination of Vitreous, Aqueous, and Plasma Concentration of OrallyAdministered Voriconazole in Humans. Archives of Ophthalmology. https://doi.org/10.1001/archopht.122.1.42
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.